[{"orgOrder":0,"company":"Medical Developments International","sponsor":"PERUKI | Quintiles Inc","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRALIA","productType":"Miscellaneous","year":"2017","type":"Inapplicable","leadProduct":"Methoxyflurane","moa":"GABA-A receptor; anion channel | Glycine receptor (alpha-1\/beta)","graph1":"Neurology","graph2":"Phase III","graph3":"Medical Developments International","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Inhalation","sponsorNew":"Medical Developments International \/ PERUKI | Quintiles Inc","highestDevelopmentStatusID":"10","companyTruncated":"Medical Developments International \/ PERUKI | Quintiles Inc"},{"orgOrder":0,"company":"Medical Developments International","sponsor":"ORION Clinical Services","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRALIA","productType":"Miscellaneous","year":"2011","type":"Inapplicable","leadProduct":"Methoxyflurane","moa":"GABA-A receptor; anion channel | Glycine receptor (alpha-1\/beta)","graph1":"Neurology","graph2":"Phase III","graph3":"Medical Developments International","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Medical Developments International \/ ORION Clinical Services","highestDevelopmentStatusID":"10","companyTruncated":"Medical Developments International \/ ORION Clinical Services"}]

Find Clinical Drug Pipeline Developments & Deals by Medical Developments International

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          AllPack Indonesia
                          Not Confirmed
                          AllPack Indonesia
                          Not Confirmed

                          Details : Methoxyflurane is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Acute Pain.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          July 12, 2017

                          Lead Product(s) : Methoxyflurane

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase III

                          Sponsor : PERUKI | Quintiles Inc

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          AllPack Indonesia
                          Not Confirmed
                          AllPack Indonesia
                          Not Confirmed

                          Details : Methoxyflurane is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Pain.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          August 19, 2011

                          Lead Product(s) : Methoxyflurane

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase III

                          Sponsor : ORION Clinical Services

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank